Thema: PLONCTH00011
Molecure, PLONCTH00011
money-1715383_1920.jpg - Foto: THN
Molecure stock quote holds at EUR 1.32 late on October 29
The Molecure stock quote was recorded at EUR 1.32 late on October 29. The company remains focused on clinical milestones ahead of its next report.
ad-hoc-news.de, heute 01:08 Uhr
Molecure, PLONCTH00011
Molecure stock: Molecure appoints Piotr Lutostanski. Results ...
Molecure appointed Piotr Lutostanski on October 6, 2026. The next report is due October 30, 2026, while Molecure stock tracks clinical milestones.
ad-hoc-news.de, 23.10.26 04:27 Uhr
Molecure, PLONCTH00011
Molecure appoints Lutostanski: Molecure stock costs EUR ...
First-half net loss fell to PLN 6.31 million. Molecure stock costs EUR 1.40 on October 20, 2026. The next report is due October 30, 2026.
ad-hoc-news.de, 20.10.26 13:51 Uhr
Molecure, PLONCTH00011
Molecure targets 50 patients: Molecure stock has PLN 156.3 ...
The 43-patient trial count gives Molecure stock a clinical marker as of early October 2026. Results are due October 30, 2026.
ad-hoc-news.de, 18.10.26 12:51 Uhr
Molecure, PLONCTH00011
Molecure reports lower half-year loss with Molecure stock ...
Net loss fell to PLN 6.31 million in the first half of 2026. Molecure stock costs EUR 1.44 on October 15, 2026, with PLN 157.0 million market value.
ad-hoc-news.de, 15.10.26 13:53 Uhr
Molecure, PLONCTH00011
Molecure appoints Piotr Lutostanski and Molecure stock costs ...
The EUR 1.51 quote dated October 8, 2026 followed EUR 1.50. Molecure stock stood at EUR 1.51 versus EUR 1.50, a plus 0.67 percent change.
ad-hoc-news.de, 08.10.26 16:09 Uhr
Molecure, PLONCTH00011
Molecure reports lower half-year loss as Molecure stock ...
Molecure stock was last at PLN 7.10 on October 5, 2026, while first-half revenue fell to PLN 1.86447 million. Net loss narrowed to PLN 6.30707 million.
ad-hoc-news.de, 05.10.26 18:58 Uhr
Molecure, PLONCTH00011
Molecure reports first-half loss and Molecure stock gains ...
